Riskpilot← Back to searchSign inGet full accessAxem AB
ABActiveOrg 5591609655Kungsholms Kyrkoplan 1 Lgh 1101Medical specialists activities · NACE 8622Est. 20181 employees
Revenue 2025
SEK 3,1M
-8% vs 2024
EBITDA margin
143.9%
+88% vs 2024
Equity ratio
60.1%
Financial strength
Net profit 2025
SEK 2,9M
+108% vs 2024
| Revenue | SEK 3,1M | -8% |
| EBITDA | SEK 4,4M | +88% |
| Net profit | SEK 2,9M | +108% |
| Total assets | SEK 12,9M | +45% |
| Equity | SEK 7,7M | +49% |
| Employees | 1 | — |
Legal name
Axem AB
Org number
5591609655
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
31 maj 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva specialistsjukvård, konsultverksamhet, forskning och utveckling inom medicin och medicinteknik, naturvetenskap och därmed förenlig verksamhet. Tjänsterna kan också anlitas av bemanningsföretag. Bolaget ska vidare även bedriva förvaltning av värdepapper, samt därmed förenlig verksamhet.
Address
Kungsholms Kyrkoplan 1 Lgh 1101
Email
axel_emilson@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 419 | 3 301 | 3 289 | 3 330 | 3 070 |
| Staff expenses | — | −672 | −785 | −884 | −886 |
| EBITDA | 1 133 | 2 472 | 2 399 | 2 345 | 4 419 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 1 133 | 2 472 | 2 399 | 2 345 | 4 419 |
| Net financials | 47 | −116 | 89 | 70 | 261 |
| Profit before tax | 886 | 1 767 | 1 861 | 1 773 | 3 557 |
| Tax | −183 | −379 | −388 | −397 | −695 |
| Net profit | 703 | 1 388 | 1 473 | 1 375 | 2 862 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 747 | 5 489 | 7 127 | 8 878 | 12 854 |
| Equity | 2 299 | 3 244 | 4 113 | 5 183 | 7 722 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 1 726 | 932 | 1 075 | 1 112 | 1 426 |
| Total debt | 1 726 | 932 | 1 075 | 1 112 | 1 426 |
EBITDA margin
143.9%
This company
15.8%
Market median
+811% vs market
20212025
Equity ratio
60.1%
This company
38.2%
Market median
+57% vs market
20212025
Return on equity
37.1%
This company
18.4%
Market median
+102% vs market
20212025
Net profit margin
93.2%
This company
8.1%
Market median
+1051% vs market
20212025
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20212025
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AM Chief Auditor | Chief Auditor | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Axem AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Marie Svedare | Chief Auditor | 0 companies |
| Axel Otto Emilson | Board of Directors | 0 companies |
| Karin Eva Christina Emilson | Deputy Board Member | 0 companies |